Divisions over the regulation of lecanemab.

Autor: De Strooper B; University of Leuven, Leuven, Belgium; University College London, London, UK., Haass C; Ludwig-Maximilians-Universität München, Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany., Hardy J; University College London, London, UK., Zetterberg H; University College London, London, UK; University of Gothenburg, Gothenburg 405 30, Sweden; University of Wisconsin-Madison, Madison, WI, USA. Electronic address: henrik.zetterberg@clinchem.gu.se.

Publikováno v: Lancet (London, England) [Lancet] 2024 Nov 30; Vol. 404 (10468), pp. 2160-2161. Date of Electronic Publication: 2024 Nov 14.

GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).

Autor: Katzdobler S; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), Munich, Germany., Nübling G; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany., Klietz M; Department of Neurology, Hanover Medical School, Hanover, Germany., Fietzek UM; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany., Palleis C; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany., Bernhardt AM; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany.; Clinical Mass Spectrometry Center Munich, Munich, Germany., Wegner F; Department of Neurology, Hanover Medical School, Hanover, Germany., Huber M; Department of Neurology, Hanover Medical School, Hanover, Germany., Rogozinski S; Department of Neurology, Hanover Medical School, Hanover, Germany., Schneider LS; Department of psychiatry and neuroscience, Charité-Universitätsmedizin Berlin, Berlin, Germany., Spruth EJ; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany., Beyle A; Department of Neurology, University of Bonn, Bonn, Germany., Vogt IR; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany., Brandt M; German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.; Department of Neurology, Technische Universität Dresden, Dresden, Germany., Hansen N; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany., Glanz W; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.; Institute of Cognitive Neurology and Dementia Research, Otto-Von-Guericke University, Magdeburg, Germany.; Clinic for Neurology, Medical Faculty, University Hospital Magdeburg, Magdeburg, Germany., Brockmann K; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Spottke A; Department of Neurology, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany., Hoffmann DC; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany., Peters O; Department of psychiatry and neuroscience, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany., Priller J; Department of Psychiatry and Psychotherapy, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Neuropsychiatry Unit and Laboratory of Molecular Psychiatry, Charité, Universitätsmedizin Berlin and DZNE, Berlin, Germany.; Centre for Clinical Brain Sciences, UK Dementia Research Institute at the University of Edinburgh, University of Edinburgh, Edinburgh, UK., Wiltfang J; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany.; Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal., Düzel E; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.; Institute of Cognitive Neurology and Dementia Research, Otto-Von-Guericke University, Magdeburg, Germany.; Institute of Cognitive Neuroscience, University College London, London, UK., Schneider A; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany.; Dept. of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, University of Bonn Medical Center, Bonn, Germany., Falkenburger B; German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.; Department of Neurology, Technische Universität Dresden, Dresden, Germany., Klockgether T; Department of Neurology, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany., Gasser T; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Nuscher B; Chair of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany., Haass C; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany.; Chair of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany., Höglinger G; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Guenter.Hoeglinger@med.uni-muenchen.de.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. Guenter.Hoeglinger@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany. Guenter.Hoeglinger@med.uni-muenchen.de., Levin J; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Johannes.levin@med.uni-muenchen.de.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. Johannes.levin@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany. Johannes.levin@med.uni-muenchen.de.; Graduate School of Systemic Neurosciences (GSN), Munich, Germany. Johannes.levin@med.uni-muenchen.de.; Clinical Mass Spectrometry Center Munich, Munich, Germany. Johannes.levin@med.uni-muenchen.de.

Publikováno v: Journal of neurology [J Neurol] 2024 Oct; Vol. 271 (10), pp. 6991-6999. Date of Electronic Publication: 2024 Sep 10.

Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer's disease.

Autor: Zatcepin A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany. Artem.Zatcepin@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. Artem.Zatcepin@med.uni-muenchen.de., Gnörich J; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Rauchmann BS; Institute of Neuroradiology, University Hospital LMU, Munich, Germany.; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany., Bartos LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Wagner S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Franzmeier N; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Malpetti M; Department of Clinical Neurosciences, Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, UK., Xiang X; Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, LMU Munich, Munich, Germany.; CAS Key Laboratory of Brain Connectome and Manipulation, the Brain Cognition and Brain Disease Institute, Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, ShenzhenShenzhen, 518055, China., Shi Y; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Parhizkar S; Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA., Grosch M; German Center for Vertigo and Balance Disorders, University Hospital of Munich, LMU Munich, Munich, Germany., Wind-Mark K; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Kunte ST; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Beyer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Meyer C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Brösamle D; German Center for Neurodegenerative Disease (DZNE), Neuroimmunology and Neurodegenerative Diseases, Göttingen, Germany.; Dept. of Cellular Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany.; Metabolic Biochemistry, Faculty of Medicine, Biomedical Center Munich (BMC), LMU Munich, Munich, Germany., Wendeln AC; German Center for Neurodegenerative Disease (DZNE), Neuroimmunology and Neurodegenerative Diseases, Göttingen, Germany.; Dept. of Cellular Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany., Osei-Sarpong C; Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseasesand , University of Bonn and West German Genome Center, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Immunogenomics & Neurodegeneration, Bonn, Germany., Heindl S; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany., Liesz A; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Stoecklein S; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Biechele G; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Finze A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Eckenweber F; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Lindner S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Rominger A; Department of Nuclear Medicine, Inselpital, Bern University Hospital, University of Bern, Bern, Switzerland., Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Willem M; Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, LMU Munich, Munich, Germany., Tahirovic S; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Herms J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany., Buerger K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany., Simons M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany., Haass C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, LMU Munich, Munich, Germany., Rupprecht R; Department of Psychiatry and Psychotherapy, University of Regensburg, Molecular Neurosciences, Regensburg, Germany., Riemenschneider MJ; Department of Neuropathology, Regensburg University Hospital, Regensburg, Germany., Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, 69120, Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), 91054, Erlangen, Germany., Beyer M; Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseasesand , University of Bonn and West German Genome Center, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Immunogenomics & Neurodegeneration, Bonn, Germany., Neher JJ; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; German Center for Neurodegenerative Disease (DZNE), Neuroimmunology and Neurodegenerative Diseases, Göttingen, Germany.; Dept. of Cellular Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany.; Metabolic Biochemistry, Faculty of Medicine, Biomedical Center Munich (BMC), LMU Munich, Munich, Germany., Paeger L; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Levin J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Neurology, University Hospital, LMU Munich, Munich, Germany., Höglinger GU; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Neurology, University Hospital, LMU Munich, Munich, Germany.; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany., Perneczky R; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, W6 8RP, UK.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, S10 2HQ, UK., Ziegler SI; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Publikováno v: Molecular neurodegeneration [Mol Neurodegener] 2024 Sep 05; Vol. 19 (1), pp. 64. Date of Electronic Publication: 2024 Sep 05.

Author Correction: Gel-like inclusions of C-terminal fragments of TDP-43 sequester stalled proteasomes in neurons.

Autor: Riemenschneider H; German Center for Neurodegenerative Diseases (DZNE), Munich, Feodor-Lynen-Str. 17, 81377, Munich, Germany., Guo Q; Department of Molecular Structural Biology, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.; State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, 100871, China., Bader J; Department of Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany., Frottin F; Department of Cellular Biochemistry, Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany.; Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, 91198, Gif-sur-Yvette, France., Farny D; German Center for Neurodegenerative Diseases (DZNE), Munich, Feodor-Lynen-Str. 17, 81377, Munich, Germany., Kleinberger G; German Center for Neurodegenerative Diseases (DZNE), Munich, Feodor-Lynen-Str. 17, 81377, Munich, Germany., Haass C; German Center for Neurodegenerative Diseases (DZNE), Munich, Feodor-Lynen-Str. 17, 81377, Munich, Germany.; Chair of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany.; Munich Cluster of Systems Neurology (SyNergy), Feodor-Lynen-Str. 17, 81377, Munich, Germany., Mann M; Department of Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany., Hartl FU; Department of Cellular Biochemistry, Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany.; Munich Cluster of Systems Neurology (SyNergy), Feodor-Lynen-Str. 17, 81377, Munich, Germany., Baumeister W; Department of Molecular Structural Biology, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany., Hipp MS; Department of Cellular Biochemistry, Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany.; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Oldenburg, Germany., Meissner F; Department of Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany.; Institute of Innate Immunity, Department of Systems Immunology and Proteomics, Medical Faculty, University of Bonn, Bonn, Germany., Fernández-Busnadiego R; Department of Molecular Structural Biology, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany. ruben.fernandezbusnadiego@med.uni-goettingen.de.; Institute of Neuropathology, University Medical Center Göttingen, 37099, Göttingen, Germany. ruben.fernandezbusnadiego@med.uni-goettingen.de.; Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, 37075, Göttingen, Germany. ruben.fernandezbusnadiego@med.uni-goettingen.de., Edbauer D; German Center for Neurodegenerative Diseases (DZNE), Munich, Feodor-Lynen-Str. 17, 81377, Munich, Germany. dieter.edbauer@dzne.de.; Munich Cluster of Systems Neurology (SyNergy), Feodor-Lynen-Str. 17, 81377, Munich, Germany. dieter.edbauer@dzne.de.; Graduate School of Systemic Neurosciences (GSN), Ludwig-Maximilians-University Munich, 81377, Munich, Germany. dieter.edbauer@dzne.de.

Publikováno v: EMBO reports [EMBO Rep] 2024 Jul; Vol. 25 (7), pp. 3161.

APOE and immunity: Research highlights.

Autor: Kloske CM; Alzheimer's Association, Chicago, Illinois, USA., Barnum CJ; INmune Bio, Inc, La Jolla, California, USA., Batista AF; Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Departments of Neurology, Harvard Medical School, Boston, Massachusetts, USA., Bradshaw EM; Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA., Brickman AM; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, G.H. Sergievsky Center, and Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA., Bu G; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA., Dennison J; Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA., Gearon MD; Department of Physiology, University of Kentucky, Lexington, Kentucky, USA., Goate AM; Department of Genetics & Genomic Sciences, Ronald M. Loeb Center for Alzheimer's disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Haass C; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany 3 Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Heneka MT; Luxembourg Centre for Systems Biomedicine (LCSB) University of Luxembourg, Esch-sur-Alzette, Luxembourg., Hu WT; Department of Neurology, Rutgers-Robert Wood Johnson Medical School and Center for Healthy Aging, Rutgers Institute for Health, Health Care Policy, and Aging Research, New Brunswick, New Jersey, USA., Huggins LKL; Department of Biology, Duke University, Durham, North Carolina, USA.; Yale School of Medicine, New Haven, Connecticut, USA., Jones NS; Interdisciplinary Program in Neuroscience, Georgetown University, Washington, District of Columbia, USA., Koldamova R; EOH, School of Public Health University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Lemere CA; Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Departments of Neurology, Harvard Medical School, Boston, Massachusetts, USA., Liddelow SA; Neuroscience Institute and Departments of Neuroscience & Physiology and of Ophthalmology, NYU Grossman School of Medicine, New York, New York, USA., Marcora E; Ronald M. Loeb Center for Alzheimer's disease, Dept. of Genetics & Genomic Sciences, Dept. of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Marsh SE; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Nielsen HM; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden., Petersen KK; The Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA., Petersen M; Department of Family Medicine, Institute of Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA., Piña-Escudero SD; Global Brain Health Institute, Department of Neurology, University of California, San Francisco, California, USA., Qiu WQ; Boston University School of Medicine, Boston, Massachusetts, USA., Quiroz YT; Departments of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Reiman E; Banner Alzheimer's Institute, Phoenix, Arizona, USA.; Banner Research, Phoenix, Arizona, USA., Sexton C; Alzheimer's Association, Chicago, Illinois, USA., Tansey MG; Department of Neuroscience and Center for Translational Research in Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, Florida, USA., Tcw J; Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA., Teunissen CE; Neurochemistry Laboratory, Clinical Chemistry department, Amsterdam Neuroscience, Program Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Tijms BM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands., van der Kant R; Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), VU University Amsterdam, Amsterdam, The Netherlands.; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands., Wallings R; CTRND, Department of Neuroscience, University of Florida, Florida, USA., Weninger SC; FBRI, Cambridge, Massachusetts, USA., Wharton W; School of Nursing, EmoryUniversity, Atlanta, Georgia, USA., Wilcock DM; Sanders-Brown Center on Aging and Department of Physiology, University of Kentucky, Lexington, Kentucky, USA., Wishard TJ; Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California, USA., Worley SL; Independent science writer, Bryn Mawr, Pennsylvania, USA., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China., Carrillo MC; Alzheimer's Association, Chicago, Illinois, USA.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2023 Jun; Vol. 19 (6), pp. 2677-2696. Date of Electronic Publication: 2023 Mar 28.